We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
(+16%)
Cap. Flow
+$7.6B
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.28B |
| 2 |
Microsoft
MSFT
|
+$517M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$351M |
| 4 |
Apple
AAPL
|
+$302M |
| 5 |
Wells Fargo
WFC
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$685M |
| 2 |
Vanguard Extended Market ETF
VXF
|
+$566M |
| 3 |
Entergy
ETR
|
+$367M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$340M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.22% |
| 2 | Technology | 11.9% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 7.32% |
| 5 | Communication Services | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
PagerDuty
PD
$816M
| $347K | ﹤0.01% |
+14,844
| New | +$365K |
|
3652
Rhythm Pharmaceuticals
RYTM
$6.81B
| $347K | ﹤0.01% |
15,152
+3,846
| +34% | +$85.4K |
|
3653
American Vanguard Corp
AVD
$68.4M
| $346K | ﹤0.01% |
17,709
-4,544
| -20% | -$71.5K |
|
|
EDN
3654
Edenor
EDN
$1.17B
| $345K | ﹤0.01% |
55,250
-10,984
| -17% | -$62.7K |
|
3655
Red Robin
RRGB
$145M
| $345K | ﹤0.01% |
10,452
-41,013
| -80% | -$1.21M |
|
3656
Great Southern Bancorp
GSBC
$874M
| $343K | ﹤0.01% |
5,426
-2,073
| -28% | -$125K |
|
3657
1-800-Flowers.com
FLWS
$250M
| $342K | ﹤0.01% |
23,564
+731
| +3% | +$9.94K |
|
|
SPNS
3658
DELISTED
Sapiens International
SPNS
| $342K | ﹤0.01% |
14,853
+4,696
| +46% | +$102K |
|
|
XLNX
3659
PUT
DELISTED
Xilinx Inc
XLNX
| $342K | ﹤0.01% |
3,500
-61,500
| -95% | -$5.78M |
|
3660
Barclays
BCS
$92.7B
| $341K | ﹤0.01% |
35,856
+22,050
| +160% | +$190K |
|
|
CYBE
3661
DELISTED
Cyberoptics Corp
CYBE
| $340K | ﹤0.01% |
+18,500
| New | +$314K |
|
|
PEI
3662
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $339K | ﹤0.01% |
4,242
+140
| +3% | +$11.7K |
|
|
SPPI
3663
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $338K | ﹤0.01% |
92,870
+1,193
| +1% | +$9.64K |
|
3664
Adtran
ADTN
$689M
| $337K | ﹤0.01% |
34,031
-3,972
| -10% | -$37.9K |
|
3665
KRONOS Worldwide
KRO
$693M
| $337K | ﹤0.01% |
25,063
-36,890
| -60% | -$483K |
|
3666
Brown-Forman Class A
BF.A
$13.4B
| $336K | ﹤0.01% |
+5,349
| New | +$328K |
|
3667
ProShares UltraPro Short QQQ
SQQQ
$2.04B
| $336K | ﹤0.01% |
24
+13
| +118% | +$222K |
|
|
SRDX
3668
DELISTED
Surmodics
SRDX
| $334K | ﹤0.01% |
8,075
-1,397
| -15% | -$58.8K |
|
3669
TherapeuticsMD
TXMD
$23.5M
| $334K | ﹤0.01% |
2,762
+12
| +0.4% | +$1.73K |
|
3670
Orion Group Holdings
ORN
$396M
| $333K | ﹤0.01% |
+64,204
| New | +$319K |
|
3671
Waterstone Financial
WSBF
$370M
| $331K | ﹤0.01% |
17,394
-3,510
| -17% | -$64.6K |
|
|
TSC
3672
DELISTED
TriState Capital Holdings, Inc.
TSC
| $331K | ﹤0.01% |
12,683
-6,274
| -33% | -$149K |
|
3673
Fresenius Medical Care
FMS
$13.8B
| $330K | ﹤0.01% |
+8,944
| New | +$317K |
|
3674
Team
TISI
$79.5M
| $330K | ﹤0.01% |
2,067
-760
| -27% | -$129K |
|
|
PDLI
3675
DELISTED
PDL BioPharma, Inc.
PDLI
| $330K | ﹤0.01% |
101,737
+16,091
| +19% | +$46.7K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2019 Portfolio in Review
As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.
- Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
- Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
- Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
- Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
- Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
- Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.